Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) gapped down before the market opened on Wednesday after Susquehanna lowered their price target on the stock from $310.00 to $258.00. The stock had previously closed at $233.62, but opened at $217.97. Susquehanna currently has a neutral rating on the stock. Astera Labs shares last traded at $226.2720, with a volume of 1,677,585 shares trading hands.
Other equities analysts have also issued reports about the company. Barclays upped their target price on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. Jefferies Financial Group raised their price target on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Morgan Stanley lifted their price target on shares of Astera Labs from $240.00 to $335.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. TD Cowen cut their price target on shares of Astera Labs from $375.00 to $300.00 and set a “hold” rating on the stock in a report on Monday, October 19th. Finally, Weiss Ratings downgraded shares of Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a research note on Friday, October 23rd. Twelve investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and an average price target of $324.37.
Read Our Latest Report on Astera Labs
Insider Activity at Astera Labs
In other news, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief operating officer directly owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. The trade was a 7.49% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Jitendra Mohan sold 90,630 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This trade represents a 6.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 408,558 shares of company stock worth $127,306,034 over the last quarter. 10.40% of the stock is owned by corporate insiders.
Trending Headlines about Astera Labs
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Astera Labs reported Q3 earnings of $1.32 per share, above the $1.19 consensus, and revenue of $584.9 million, beating estimates of $550.78 million. Revenue rose 154% year over year and 49% sequentially. The company also said its outlook topped estimates. Astera Labs Q3 results
- Positive Sentiment: Scorpio fabric switches became Astera Labs’ largest product family, led by volume production of the Scorpio X-Series 320-lane switch, signaling strong demand for its AI-infrastructure connectivity products. Astera Labs Q3 results
- Positive Sentiment: Northland Securities upgraded ALAB from “market perform” to “outperform” and set a $315 price target, indicating confidence in further upside. Northland Securities recommendations
- Negative Sentiment: Susquehanna lowered its price target from $310 to $258 and maintained a “neutral” rating. Although the new target remains above the cited share price, the reduction suggests a more cautious view. Susquehanna recommendations
- Negative Sentiment: Recent selling pressure and a break below the 200-day moving average point to technical weakness that could temper the response to the earnings beat. Astera Labs technical analysis
Institutional Trading of Astera Labs
Institutional investors have recently added to or reduced their stakes in the business. Keating Financial Advisory Services Inc. bought a new position in shares of Astera Labs in the 2nd quarter worth about $25,000. GK Wealth Management LLC bought a new stake in shares of Astera Labs during the 3rd quarter valued at about $29,000. Archer Investment Corp bought a new stake in shares of Astera Labs during the 2nd quarter valued at about $30,000. Signature Equity Partners LLC grew its position in shares of Astera Labs by 1,680.0% during the 3rd quarter. Signature Equity Partners LLC now owns 89 shares of the company’s stock valued at $32,000 after buying an additional 84 shares during the last quarter. Finally, Whipplewood Advisors LLC raised its stake in Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after acquiring an additional 319 shares during the period. Institutional investors own 60.47% of the company’s stock.
Astera Labs Stock Down 4.4%
The stock has a market cap of $38.73 billion, a price-to-earnings ratio of 111.27 and a beta of 3.85. The firm’s 50 day moving average is $306.13 and its two-hundred day moving average is $255.53.
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.13. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $584.90 million for the quarter, compared to analysts’ expectations of $550.78 million. During the same quarter last year, the company posted $0.49 earnings per share. Astera Labs’s revenue was up 153.6% on a year-over-year basis. On average, analysts anticipate that Astera Labs, Inc. will post 2.71 EPS for the current fiscal year.
About Astera Labs
Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.
The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.
Featured Articles
- Five stocks we like better than Astera Labs
- Advanced Micro Devices’ Q3 Results Answer a Big Question, But Another Remains
- High Voltage Returns: Talen Energy Powers the Data Center Rush
- 3 Dividend Increases Above 10%, But Which Offers the Most Income?
- Meta’s $100 Billion AI Financing Plan Has a Catch for Existing Shareholders
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
